{
  "id": 1767431087352,
  "title": "Optic Neuropathy: Assessment & Management",
  "summary": "The optic nerve is vulnerable to injury from numerous local and systemic diseases. This guide outlines the clinical features, systematic assessment approach, and specific management of typical optic neuritis.",
  "date": "2026-01-03T09:04:47.352Z",
  "data": {
    "title": "Optic Neuropathy: Assessment & Management",
    "summary": "The optic nerve is vulnerable to injury from numerous local and systemic diseases. This guide outlines the clinical features, systematic assessment approach, and specific management of typical optic neuritis.",
    "summary_illustration": "<svg viewBox='0 0 100 100' xmlns='http://www.w3.org/2000/svg'><circle cx='50' cy='50' r='40' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><circle cx='50' cy='50' r='10' fill='hsl(215, 90%, 45%)'/><path d='M50 50 L90 50' stroke='hsl(215, 90%, 45%)' stroke-width='4' stroke-linecap='round'/><path d='M30 35 Q50 10 70 35' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='1'/></svg>",
    "sections": [
      {
        "title": "Clinical Features & Recognition",
        "icon": "visibility",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "dVA (decreased Visual Acuity)",
          "Relative/complete afferent pupillary defect (RAPD)",
          "dlight sensitivity",
          "dcolour vision",
          "VF (Visual Field) defects",
          "Optic disc abnormalities: Swelling (early) and Pallor (late)",
          "Note: Diagnosis is more difficult in early symmetric disease where objective signs may be absent.",
          "Note: Typical features may be seen in retinal disorders (central scotoma, dcolour vision, 2° optic atrophy)."
        ]
      },
      {
        "title": "URGENT INVESTIGATION REQUIRED",
        "icon": "warning",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Unexplained optic neuropathy requires urgent investigation to rule out serious disease such as compression 2° to a tumour.",
          "See Atypical optic neuritis (p. 742) for further guidance."
        ]
      },
      {
        "title": "Table 16.1: Systematic Approach to Assessment (History)",
        "icon": "history",
        "type": "table",
        "layout": "full_width",
        "color_theme": "purple",
        "content": {
          "headers": [
            "Category",
            "Assessment Components"
          ],
          "rows": [
            [
              "PC (Presenting Complaint)",
              "Blurring, ‘washout’ of colours, ‘blind spots’; may be asymptomatic; check duration, speed of onset/ recovery, precipitants, associations (diplopia, proptosis, red eye)"
            ],
            [
              "HPC",
              "Recent trauma or surgery"
            ],
            [
              "POH",
              "Previous/ current eye disease; refractive error"
            ],
            [
              "PMH",
              "Vascular risk factors and disease; neurological disease (e.g. MS); connective tissue disease (e.g. SLE, RA); granulomatous disease (e.g. sarcoidosis, TB)"
            ],
            [
              "SR (Systems Review)",
              "Detailed review of all systems, particularly headache or abnormalities of sensation/ motor system/ speech/ balance/ hearing and other systems (respiratory, GI, GU, ENT)"
            ],
            [
              "SH (Social History)",
              "Driver; profession; diet, tobacco consumption, alcohol intake, toxin exposure (e.g. lead, tin, or carbon monoxide)"
            ],
            [
              "FH (Family History)",
              "Family members with visual problems"
            ],
            [
              "Dx (Drugs)",
              "Previous/ current toxic drugs (e.g. anti-TB)"
            ],
            [
              "Ax (Allergies)",
              "Allergies or relevant drug contraindications"
            ]
          ]
        }
      },
      {
        "title": "Table 16.1: Systematic Approach to Assessment (Examination)",
        "icon": "clinical_notes",
        "type": "table",
        "layout": "full_width",
        "color_theme": "green",
        "content": {
          "headers": [
            "Examination",
            "Key Findings to Evaluate"
          ],
          "rows": [
            [
              "VA",
              "Best corrected/ pinhole/ near"
            ],
            [
              "Retinoscopy",
              "Rule out refractive error"
            ],
            [
              "Visual function",
              "Check for RAPD, colour vision, red desaturation, VF (confrontation VF and formal perimetry)"
            ],
            [
              "Orbit",
              "Proptosis, palpable mass, globe displacement, pulsation/ bruit"
            ],
            [
              "AS (Ant. Segment)",
              "Features suggestive of glaucoma, uveitis, carotid–cavernous fistula"
            ],
            [
              "Tonometry",
              "IOP"
            ],
            [
              "Optic disc",
              "Size, cup, colour, oedema, congenital abnormalities, flat/ elevated/ tilted, crowding, peripapillary oedema or haemorrhages, retinociliary collateral vessels, SVP"
            ],
            [
              "Macula",
              "Abnormalities which may cause central scotoma"
            ],
            [
              "Fundus",
              "Abnormalities (e.g. retinoschisis) that may cause peripheral field loss; posterior uveitis or vasculitis"
            ],
            [
              "Vessels",
              "Arteriosclerosis, hypertensive changes, occlusions, and emboli"
            ],
            [
              "CNS/ PNS",
              "Cranial nerves (including ocular motility); sensory, motor, cerebellar function; speech, mental state"
            ],
            [
              "CVS",
              "Pulse, heart sounds, carotid bruits"
            ]
          ]
        }
      },
      {
        "title": "Table 16.2: Optic Neuropathy vs Macular Disease",
        "icon": "compare",
        "type": "table",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": {
          "headers": [
            "Feature",
            "Optic Neuropathy",
            "Macular Disease"
          ],
          "rows": [
            [
              "Hx: Complaint",
              "Grey/ darkness",
              "Distortion"
            ],
            [
              "Hx: Scotoma",
              "Negative",
              "Positive"
            ],
            [
              "Assoc. Symptoms",
              "Retrobulbar pain (e.g. on eye movement)",
              "Micropsia, hyperopic shift"
            ],
            [
              "Exam: VA",
              "Variable d",
              "dd"
            ],
            [
              "Exam: Colour*",
              "d or dd (Classically Red-Green axis)",
              "Normal or mild d (Classically Blue-Yellow axis)"
            ],
            [
              "Exam: RAPD",
              "+ to ++++",
              "− or (±)"
            ],
            [
              "Testing: Perimetry",
              "Central, centrocaecal, arcuate, or altitudinal defects",
              "Central scotoma"
            ],
            [
              "Testing: Amsler",
              "Scotoma",
              "Metamorphopsia"
            ],
            [
              "Testing: VEP latency",
              "d",
              "Normal or mild d"
            ],
            [
              "*Note",
              "Exceptions exist: e.g., glaucoma preferentially affects blue-yellow axis.",
              " "
            ]
          ]
        }
      },
      {
        "title": "Typical Optic Neuritis: Definitions",
        "icon": "account_tree",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "purple",
        "content": {
          "center": "Optic Nerve Inflammation",
          "branches": [
            "Papillitis: Disc is swollen",
            "Retrobulbar Neuritis: Disc is spared",
            "Neuroretinitis: Retinal involvement with 'macular star'",
            "Commonest Cause: Demyelination"
          ]
        }
      },
      {
        "title": "Acute Demyelinating Optic Neuritis: Demographics",
        "icon": "groups",
        "type": "chart",
        "layout": "half_width",
        "color_theme": "blue",
        "content": {
          "type": "bar",
          "data": [
            {
              "label": "Incidence (per 100k/y)",
              "value": 3
            },
            {
              "label": "Occurs in known MS (%)",
              "value": 70
            },
            {
              "label": "Presenting MS Symptom (%)",
              "value": 20
            },
            {
              "label": "Female Ratio (3:1)",
              "value": 75
            }
          ]
        }
      },
      {
        "title": "Acute Demyelinating Features",
        "icon": "biotech",
        "type": "plain_text",
        "layout": "half_width",
        "color_theme": "blue",
        "content": "Aged 20–50. Usually unilateral, though bilateral involvement occurs. Rapid dVA over hours/days (rarely NPL). Recovery starts within 2wk and continues for months. Includes dcontrast sensitivity, dcolour vision, variable field loss, photopsia. Retrobulbar pain present in 90% (worse on eye movement, precedes dVA). Signs: RAPD (may be absent if pre-existing contralateral disease), disc swelling (1/3 of cases). Disc should NOT be pale in acute first episode. May have few haemorrhages, retinal exudates, and mild vitritis."
      },
      {
        "title": "Box 16.1: Features of Typical Optic Neuritis",
        "icon": "task_alt",
        "type": "remember",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": {
          "mnemonic": "TYPICAL ON",
          "explanation": "Age 20–50; Unilateral; Worsens over hours/days; Recovery starts within 2wk; Retrobulbar pain; dcolour vision; RAPD. (Source: Beck RW et al. ONTT Study)"
        }
      },
      {
        "title": "Treatment & Controversy",
        "icon": "medication",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Treatment remains controversial.",
          "IVMP (Intravenous Methylprednisolone) may hasten visual recovery but did not affect final VA in the ONTT study.",
          "No conclusive evidence that corticosteroids (IV or PO) benefit recovery of normal VA, VF, or contrast sensitivity.",
          "Corticosteroids may be offered to: 1. Those known to have MS, 2. Poor vision in the other eye, 3. Severe pain."
        ]
      },
      {
        "title": "Prognosis: Visual Recovery",
        "icon": "trending_up",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "All patients show some improvement.",
          ">90% attain 6/9 in the affected eye.",
          "Persistent abnormalities: colour perception, contrast sensitivity, stereopsis, or field may remain even if VA is >6/6.",
          "Recurrence: ~1/3 have another episode (either eye) within 5y.",
          "Poor MRI prognosis: associated with length of nerve involvement and intracanalicular segment involvement."
        ]
      },
      {
        "title": "15-Year Probability of Developing MS",
        "icon": "insights",
        "type": "chart",
        "layout": "half_width",
        "color_theme": "red",
        "content": {
          "type": "bar",
          "data": [
            {
              "label": "Normal MRI at Baseline",
              "value": 25
            },
            {
              "label": ">1 White Matter Lesion",
              "value": 72
            }
          ]
        }
      },
      {
        "title": "MS Risk Factors & Paediatric Differences",
        "icon": "child_care",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "purple",
        "content": [
          "MS Risk Factors: Female sex, multiple white matter lesions on MRI, and CSF oligoclonal bands.",
          "Paediatric Optic Neuritis: Differs from adults; commonly bilateral; disc swelling is more often present.",
          "Paediatric MS Risk: Associated with white matter lesions on brain imaging at presentation, presence of oligoclonal bands in CSF, and older age at presentation."
        ]
      },
      {
        "title": "Diagnostic Summary",
        "icon": "terminal",
        "type": "plain_text",
        "layout": "full_width",
        "color_theme": "blue",
        "content": "Diagnosis of typical episodes may be made on clinical grounds alone. If the episode is atypical, investigate to rule out a progressive optic neuropathy (see Atypical optic neuritis, p. 742). Electrodiagnostic tests (EDTs) may be helpful in early symmetric disease where objective signs are absent."
      }
    ]
  },
  "chapterId": "neuro",
  "seqId": 12,
  "_serverSynced": true
}